Vaginal yeast infection

Aug 14, 2020

Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis

Jun 09, 2020

Lupin Signs Marketing Agreement With Ceek for Women's Health Products to Improve OB/GYN and Patient Exam Experience

Jun 09, 2020

Ceek and Lupin Sign a Marketing Agreement to Improve OB/GYN and Patient Exam Experience with the Nella® Products

May 04, 2020

Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis

Apr 22, 2020

Lupin Announces SOLOSEC® (secnidazole) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.